Rising Prevalence of Hematological Disorders Fosters Growth in Immunohematology Market

Some of the most notable and prominent factors influencing the demand dynamics in the global immunohematology market include increasing awareness among the global population pertaining to the importance of blood donation as well as rising requirement for effective detection and diagnosis of blood related diseases. Various public as well as private entities, along with various non-governmental organizations or NGOs are organizing awareness campaigns to underscore the importance of blood donation. Several organizations are also promoting awareness regarding to the usage of safe blood and blood products. These trends are anticipated to work favorably for the enhancement of the global immunohematology market in coming years.

Rising prevalence of various hematological disorders i.e. diseases associated with blood as well as blood forming organs, is also expected to fuel the demand in the global immunohematology market in coming years. Some of the most notable types of hematological disorders are thalassemia, leukemia, sickle cell anemia, lymphoma, and hemophilia, among others. For example, as per the study by the World Health Organization in 2020, around 4,74,519 new cases of leukemia were reported in 2020. Furthermore, more than 3,11,594 deaths were caused by leukemia in 2020. This rise in the prevalence of leukemia is anticipated to drive the demand for effective treatment and testing solutions in the global immunohematology market within the next few years.

Moreover, rising healthcare infrastructure upgradation, increase in expenditure on research and development for advancing the diagnosis as well as treatment of various hematological diseases, and favorable government policies and initiatives are also expected to foster the development in the global immunohematology market in the next few years. Advancements in the global immunohematology market have paved way for automated hematological devices, high volume sample output, enhanced patient data management, software upgradation, and increase in the storage capacities. However, these technological advancements have also surged the costs of various devices and software tools in the global immunohematology market. The high cost associated with hematology equipment such as software and devices may hamper the growth in the global immunohematology market in coming years.

Global Immunohematology Market: Snapshot 

Rapid increase in the global disease burden and rise in the demand for blood- and plasma-derived products such as platelets, immunoglobulin, and plasma factors are augmenting the demand for immunohematology testing instruments and reagents. The number of patients with different hematological and other chronic diseases is also increasing rapidly across the world. This is likely to raise the number of surgical procedures in the near future, consequently propelling the demand for blood transfusions. Demand for advanced immunohematology tests in also anticipated to increase during the forecast period in order to maintain the quality standards and safety profiles during blood transfusions.

Awareness among the general public regarding the importance of blood compatibility and transfusion-related diseases is increasing due to the development of health care infrastructure, government campaigns, and increasing per capita income in developed as well as developing countries. Awareness among patients about proper compatibility tests for transfusion is also increasing. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. Moreover, government reimbursement programs in developed as well as developing countries are likely to provide growth opportunities to the immunohematology market in the near future. Demand–supply gap of safe and adequate human blood and plasma is a major bottleneck in the blood transfusion & blood typing industry. According to the World Health Organization, there is a significant difference between the blood demand–supply gap in developing countries and that in developed countries. Developed countries account for more than 50% of the global blood collections. These countries represent only 19% of the global population. Supply disorders in both source materials and finished products, if not managed properly, can hamper the global immunohematology market during the forecast period.

immunohematology-market.jpg

Advancements in the immunohematology technology have led to rapid development in the diagnostic approach toward in vitro study of the antigen–antibody interaction, facilitating improvement in the compatibility reaction between the donor’s blood and the recipient’s blood. Technological improvements in devices and reagents available for immunohematology testing have enabled clinicians to provide proper emergency assistance to patients. These technological advancements include development of automated systems which make the identification process easier and provide more accurate results as compared to manual systems.

Based on product, the global immunohematology market has been segmented into analyzers and reagents. The analyzers segment has been sub-segmented into automatic analyzers and semi-automatic/non-automatic analyzers. Based on application, the global immunohematology market has been divided into blood typing and antibody screening.  Based on end-user, the market has been classified into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant during the forecast period, due to increasing usage of automated analyzers with high throughput in hospitals.

Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2016 and is projected to continue its dominance between 2017 and 2025. Growth of the market in North America is primarily attributable to the increased funding by governments and the private sector and large volumes of blood transfusions. In addition, increased focus on research by pharmaceutical companies and well-established health care infrastructure are major factors driving the market in the region. The market in Europe is projected to expand at a significant CAGR from 2017 to 2025. Europe held the second-largest market share in 2016. High adoption and usage of superior-quality diagnostics and treatments is one of the major factors driving the market in the region. This can be attributed to increasing number of diagnostic laboratories and blood banks, rising government funding for research activities, and growing application of immunohematology in transfusion safety in the region. Asia Pacific is one of the rapidly developing regions in the world. High per capita income has increased the consumption of blood products in the region.

Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers. These players are adopting organic and inorganic growth strategies to expand their product offerings, enhance their geographical reach, widen their customer base, and gain market share. In 2016, Grifols, S.A. won a contract for supplying blood-typing solutions to the Red Cross of South Korea. The Malaysian National Blood Bank renewed its contract for Grifols’s NAT technology that analyzes about 450,000 blood donations every year.

Immunohematology Market: Scope and Methodology

This report on the global immunohematology market analyzes the current and future prospects of the market. The report comprises a comprehensive executive summary including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research represents a bulk of our research efforts along with the information collected from telephonic interviews and interactions via e-mails. Secondary research involves the study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates of each segment of the global immunohematology market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. The report also provides insights into the key trends in the immunohematology market such as shift toward automated systems, result comparability, and standardization to adhere to the international accreditations, significant number of product approvals, and strategic alliances. The key market indicators influencing the global immunohematology market taken into consideration include cost constraints and regulatory landscape. The report also contains market attractiveness analysis of the major segments, which provides a thorough analysis of the overall competition scenario in the global immunohematology market. The report also comprises Porter’s five forces analysis of the global immunohematology market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 and the compounded annual growth rate (CAGR %) for the period from 2017 to 2025 have been provided for all segments, considering 2016 as the base year. The year-on-year growth of the global immunohematology market for each segment has also been provided. Additionally, market-related factors such as technological advancements, changing environmental factors, growing initiatives to create disease awareness, increasing affordability for patients in various geographies, and historical year-on-year growth have been taken into consideration while estimating the market size.

Immunohematology Market: Segmentation

Based on product, the global immunohematology market has been segmented into analyzers (automatic and semi-automatic/non-automatic) and reagents. Based on application, the market has been divided into blood typing and antibody screening. In terms of end-user, the market has been segmented into hospitals, academic & research institutes, diagnostic & reference laboratories, and blood banks. The hospitals segment is expected to remain dominant throughout the forecast period.

Geographically, the global immunohematology market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Every region has been further segmented into major countries in the respective region. These include the U.S. and Canada (North America), the U.K., Germany, France, Italy, and Spain (Europe), China, Australia, Japan, and India (Asia Pacific), Brazil and Mexico (Latin America), and GCC and South Africa (Middle East & Africa).

Immunohematology Market: Competition Landscape

The report also profiles major players in the immunohematology market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. A thorough market share analysis of major companies operating in the immunohematology market has been provided in the report. Key companies profiled in the report are Bio-Rad Laboratories, Inc., Grifols S.A., Ortho Clinical Diagnostics, IMMUCOR, INC., Abbott Laboratories, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Merck KGaA, and Siemens Healthineers.

The global immunohematology market has been segmented as follows:

Product

  • Immunohematology Analyzers 
    • Automatic
    • Semi-automatic/Non-automatic
  • Immunohematology Reagents   

Application

  • Blood Typing
  • Antibody Screening

End-user

  • Hospitals
    • 500+ Beds
    • 200–499 Beds
    • Less Than 200 Beds
  • Academic & Research Institutes
  • Diagnostic & Reference Laboratories
  • Blood Banks

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Australia & New Zealand
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology

Section 3 Executive Summary
3.1 Global Immunohematology Market Snapshot
3.2 Market Share Analysis, by Region, 2016
3.3 Market Opportunity Map

Section 4 Market Overview
4.1 Immunohematology Market Taxonomy
4.2 Key Market Advancements
4.3 Global Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
4.4 Global Immunohematology Market Outlook

Section 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Immunohematology Market: Porter’s Five Forces Analysis
5.6 Key Success Factors of Top 3 Companies
5.7 Estimated blood donations by WHO region , 2013
5.8 Healthcare Sector Overview

Section 6 Immunohematology Market Analysis, by Product
6.1 Introduction
6.2 Global Immunohematology Market Value Share Analysis, by Product
6.3 Global Immunohematology Market Forecast, by Product
      6.3.1 Analyzers
              6.3.1.1 Automatic
              6.3.1.2 Semi-automatic/Non-automatic
      6.3.2 Reagents
6.4 Market Attractiveness Analysis, by Product
6.5 Key Trends

Section 7 Immunohematology Market Analysis, by Application
7.1 Introduction
7.2 Global Immunohematology Market Value Share Analysis, by Application
7.3 Global Immunohematology Market Forecast, by Application
      7.3.1 Blood Typing
      7.3.2 Antibody Screening
7.4 Market Attractiveness Analysis, by Application
7.5 Key Trends

Section 8 Immunohematology Market Analysis, by End-user
8.1 Introduction
8.2 Global Immunohematology Market Value Share Analysis, by End-user
8.3 Global Immunohematology Market Forecast, by End-user
      8.3.1 Hospitals
              8.3.1.1 500+ Beds
              8.3.1.2 200–499 Beds
              8.3.1.3 Less Than 200 Beds
      8.3.2 Academic & Research Institutes
      8.3.3 Diagnostic & Reference Laboratories
      8.3.4 Blood Banks
8.4 Market Attractiveness Analysis, by End-user

Section 9 Immunohematology Market Analysis, by Region
9.1 Global Immunohematology Market Scenario
9.2 Global Immunohematology Market Value Share Analysis, by Region
9.3 Global Immunohematology Market Forecast, by Region
9.4 Market Attractiveness Analysis, by Region

Section 10 North America Immunohematology Market Analysis
10.1 Regional Outlook
10.2 Market Overview
10.3 Market Analysis, by Product
      10.3.1 Market Value Share Analysis, by Product
      10.3.2 Market Size (US$ Mn) Forecast, by Product
              10.3.2.1 Analyzers
                         10.3.2.1.1 Automatic
                         10.3.2.1.2 Semi-automatic/Non-automatic
              10.3.2.2 Reagents
10.4 Market Analysis, by Application
      10.4.1 Market Value Share Analysis, by Application
      10.4.2 Market Size (US$ Mn) Forecast, by Application
              10.4.2.1 Blood Typing
              10.4.2.2 Antibody Screening
10.5 Market Analysis, by End-user
      10.5.1 Market Value Share Analysis, by End-user
      10.5.2 Market Size (US$ Mn) Forecast, by End-user
              10.5.2.1 Hospitals
                         10.5.2.1.1 500+ Beds
                         10.5.2.1.2 200–499 Beds
                         10.5.2.1.3 Less Than 200 Beds
              10.5.2.2 Academic & Research Institutes
              10.5.2.3 Diagnostic & Reference Laboratories
              10.5.2.4 Blood Banks
10.6 Market Analysis, by Country
      10.6.1 Market Value Share Analysis, by Country
      10.6.2. Market Size (US$ Mn) Forecast, by Country, 2017–2025
              10.6.2.1 U.S.
                         10.6.2.1.1 U.S. Market Size (US$ Mn) Forecast, by Product
                         10.6.2.1.2 U.S. Market Size (US$ Mn) Forecast, by Application
                         10.6.2.1.3 U.S. Market Size (US$ Mn) Forecast, by End-user
              10.6.2.2 Canada
10.7 Market Attractiveness Analysis
      10.7.1 by Country
      10.7.2 by Product
      10.7.3 by Application
      10.7.4 by End-user

Section 11 Europe Immunohematology Market Analysis
11.1 Regional Outlook
11.2 Market Overview
11.3 Market Analysis, by Product
      11.3.1 Market Value Share Analysis, by Product
      11.3.2 Market Size (US$ Mn) Forecast, by Product
              11.3.2.1 Analyzers
                         11.3.2.1.1 Automatic
                         11.3.2.1.2 Semi-automatic/Non-automatic
      11.3.2.2 Reagents
11.4 Market Analysis, by Application
      11.4.1 Market Value Share Analysis, by Application
      11.4.2 Market Size (US$ Mn) Forecast, by Application
              11.4.2.1 Blood Typing
              11.4.2.2 Antibody Screening
11.5 Market Analysis, by End-user
      11.5.1 Market Value Share Analysis, by End-user
      11.5.2 Market Size (US$ Mn) Forecast, by End-user
              11.5.2.1 Hospitals
                         11.5.2.1.1 500+ Beds
                         11.5.2.1.2 200–499 Beds
                         11.5.2.1.3 Less Than 200 Beds
              11.5.2.2 Academic & Research Institutes
              11.5.2.3 Diagnostic & Reference Laboratories
              11.5.2.4 Blood Banks
11.6 Market Analysis, by Country/Sub-region
      11.6.1 Market Value Share Analysis, by Country/Sub-region
      11.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
              11.6.2.1 U.K.
              11.6.2.2 Germany
              11.6.2.3 France
              11.6.2.4 Spain
              11.6.2.5 Italy
              11.6.2.6 Rest of Europe
11.7 Market Attractiveness Analysis
      11.7.1 by Country/Sub-region
      11.7.2 by Product
      11.7.3 by Application
      11.7.4 by End-user

Section 12 Asia Pacific Immunohematology Market Analysis
12.1 Regional Outlook
12.2 Market Overview
12.3 Market Analysis, by Product
      12.3.1 Market Value Share Analysis, by Product
      12.3.2 Market Size (US$ Mn) Forecast, by Product
              12.3.2.1 Analyzers
                         12.3.2.1.1 Automatic
                         12.3.2.1.2 Semi-automatic/Non-automatic
      12.3.2.2 Reagents
12.4 Market Analysis, by Application
      12.4.1 Market Value Share Analysis, by Application
      12.4.2 Market Size (US$ Mn) Forecast, by Application
              12.4.2.1 Blood Typing
              12.4.2.2 Antibody Screening
12.5 Market Analysis, by End-user
      12.5.1 Market Value Share Analysis, by End-user
      12.5.2 Market Size (US$ Mn) Forecast, by End-user
              12.5.2.1 Hospitals
                         12.5.2.1.1 500+ Beds
                         12.5.2.1.2 200–499 Beds
                         12.5.2.1.3 Less Than 200 Beds
              12.5.2.2 Academic & Research Institutes
              12.5.2.3 Diagnostic & Reference Laboratories
              12.5.2.4 Blood Banks
12.6 Market Analysis, by Country/Sub-region
      12.6.1 Market Value Share Analysis, by Country/Sub-region
      12.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
              12.6.2.1 Australia & New Zealand
              12.6.2.2 Japan
              12.6.2.3 China
              12.6.2.4 India
              12.6.2.5 Rest of Asia Pacific
12.7 Market Attractiveness Analysis
      12.7.1 by Country/Sub-region
      12.7.2 by Product
      12.7.3 by Application
      12.7.4 by End-user

Section 13 Latin America Immunohematology Market Analysis
13.1 Regional Outlook
13.2 Market Overview
13.3 Market Analysis, by Product
      13.3.1 Market Value Share Analysis, by Product
      13.3.2 Market Size (US$ Mn) Forecast, by Product
              13.3.2.1 Analyzers
                         13.3.2.1.1 Automatic
                         13.3.2.1.2 Semi-automatic/Non-automatic
              13.3.2.2 Reagents
13.4 Market Analysis, by Application
      13.4.1 Market Value Share Analysis, by Application
      13.4.2 Market Size (US$ Mn) Forecast, by Application
              13.4.2.1 Blood Typing
              13.4.2.2 Antibody Screening
13.5 Market Analysis, by End-user
      13.5.1 Market Value Share Analysis, by End-user
      13.5.2 Market Size (US$ Mn) Forecast, by End-user
              13.5.2.1 Hospitals
                         13.5.2.1.1 500+ Beds
                         13.5.2.1.2 200–499 Beds
                         13.5.2.1.3 Less Than 200 Beds
              13.5.2.2 Academic & Research Institutes
              13.5.2.3 Diagnostic & Reference Laboratories
              13.5.2.4 Blood Banks
13.6 Market Analysis, by Country/Sub-region
      13.6.1 Market Value Share Analysis, by Country/Sub-region
      13.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
              13.6.2.1 Brazil
              13.6.2.2 Mexico
              13.6.2.3 Rest of Latin America
13.7 Market Attractiveness Analysis
      13.7.1 by Country/Sub-region
      13.7.2 by Product
      13.7.3 by Application
      13.7.4 by End-user

Section 14 Middle East & Africa Immunohematology Market Analysis
14.1 Regional Outlook
14.2 Market Overview
14.3 Market Analysis, by Product
      14.3.1 Market Value Share Analysis, by Product
      14.3.2 Market Size (US$ Mn) Forecast, by Product
              14.3.2.1 Analyzers
                         14.3.2.1.1 Automatic
                         14.3.2.1.2 Semi-automatic/Non-automatic
              14.3.2.2 Reagents
14.4 Market Analysis, by Application
      14.4.1 Market Value Share Analysis, by Application
      14.4.2 Market Size (US$ Mn) Forecast, by Application
              14.4.2.1 Blood Typing
              14.4.2.2 Antibody Screening
14.5 Market Analysis, by End-user
      14.5.1 Market Value Share Analysis, by End-user
      14.5.2 Market Size (US$ Mn) Forecast, by End-user
              14.5.2.1 Hospitals
                         14.5.2.1.1 500+ Beds
                         14.5.2.1.2 200–499 Beds
                         14.5.2.1.3 Less Than 200 Beds
              14.5.2.2 Academic & Research Institutes
              14.5.2.3 Diagnostic & Reference Laboratories
              14.5.2.4 Blood Banks
14.6 Market Analysis, by Country/Sub-region
      14.6.1 Market Value Share Analysis, by Country/Sub-region
      14.6.2 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
              14.6.2.1 South Africa
              14.6.2.2 GCC
              14.6.2.3 South Africa
              14.6.2.4 Israel
              14.6.2.5 Rest of Middle East & Africa
14.7 Market Attractiveness Analysis
      14.7.1 by Country/Sub-region
      14.7.2 by Product
      14.7.3 by Application
      14.7.4 by End-user

Section 15 Company Profiles
15.1 Immunohematology Market Share Analysis, by Company (2016)
15.2 Company Profiles
      15.2.1 Bio-Rad Laboratories, Inc.
              15.2.1.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.1.2 Financial Overview
              15.2.1.3 Product Portfolio
              15.2.1.4 SWOT Analysis
              15.2.1.5 Strategic Overview
      15.2.2 Grifols, S.A.
              15.2.2.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.2.2 Financial Overview
              15.2.2.3 Product Portfolio
              15.2.2.4 SWOT Analysis
              15.2.2.5 Strategic Overview
      15.2.3 Ortho Clinical Diagnostics
              15.2.3.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.3.2 Financial Overview
              15.2.3.3 Product Portfolio
              15.2.3.4 SWOT Analysis
              15.2.3.5 Strategic Overview
      15.2.4 IMMUCOR, INC.
              15.2.4.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.4.2 Financial Overview
              15.2.4.3 Product Portfolio
              15.2.4.4 SWOT Analysis
              15.2.4.5 Strategic Overview
      15.2.5 Abbott Laboratories
              15.2.5.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.5.2 Financial Overview
              15.2.5.3 Product Portfolio
              15.2.5.4 SWOT Analysis
              15.2.5.5 Strategic Overview
      15.2.6 Beckman Coulter, Inc.
              15.2.6.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.6.2 Financial Overview
              15.2.6.3 Product Portfolio
              15.2.6.4 SWOT Analysis
              15.2.6.5 Strategic Overview
      15.2.7 Thermo Fisher Scientific, Inc.
              15.2.7.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.7.2 Financial Overview
              15.2.7.3 Product Portfolio
              15.2.7.4 SWOT Analysis
              15.2.7.5 Strategic Overview
      15.2.8 Becton, Dickinson and Company
              15.2.8.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.8.2 Financial Overview
              15.2.8.3 Product Portfolio
              15.2.8.4 SWOT Analysis
              15.2.8.5 Strategic Overview
      15.2.9 Merck KGaA
              15.2.9.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.9.2 Financial Overview
              15.2.9.3 Product Portfolio
              15.2.9.4 SWOT Analysis
              15.2.9.5 Strategic Overview
      15.2.10 Siemens Healthineers14.2.5 Merck & Co., Inc.
              15.2.10.1 Company Overview (HQ, Business Segments, Employee Strength)
              15.2.10.2 Financial Overview
              15.2.10.3 Product Portfolio
              15.2.10.4 SWOT Analysis
              15.2.10.5 Strategic Overview

List of Tables

Table 01: Global Immunohematology Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 03: Global Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 04: Global Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 06: Global Immunohematology Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 08: North America Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 09: North America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 10: North America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 11: North America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 12: North America Immunohematology Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 13: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 14: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 15: U.S. Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 16: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 17: U.S. Immunohematology Market Size (US$ Mn) Forecast, by Hospitals (by Analyzers), 2015–2025
Table 18: Europe Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 19: Europe Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 20: Europe Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 21: Europe Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22: Europe Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 23: Europe Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 24: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 25: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 26: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Application, 2017–2025
Table 27: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 28: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 29: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
Table 30: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 31: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Analyzer, 2015–2025
Table 32: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 34: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 36: Latin America Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 37: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Product, 2017–2025
Table 38: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Analyzers, 2015–2025
Table 39: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 41: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Hospitals, 2015–2025
Table 42: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

List of Figures

Figure 01: Global Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 02: Market Value Share, by Product (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by Region (2016)
Figure 05: Global Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 06: Global Immunohematology Market Value Share Analysis, by Analyzers, 2016 and 2025
Figure 07: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2015–2025
Figure 08: Global Immunohematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2015–2025
Figure 09: Global Immunohematology Market Attractiveness Analysis, by Product
Figure 10: Global Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 11: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Typing, 2015–2025
Figure 12: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antibody Screening, 2015–2025
Figure 13: Global Immunohematology Market Attractiveness, by Application
Figure 14: Global Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 15: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2015–2025
Figure 16: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic & Research Institutes, 2015–2025
Figure 17: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic & Reference Laboratories, 2015–2025
Figure 18: Global Immunohematology Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Blood Banks, 2015–2025
Figure 19: Global Immunohematology Market Attractiveness, by End-user
Figure 20: Global Immunohematology Market Value Share, by Region, 2016 and 2025
Figure 21: Global Immunohematology Market Attractiveness, by Region
Figure 22: North America Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 23: North America Market Attractiveness Analysis, by Country
Figure 24: North America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 25: North America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 26: North America Immunohematology Market Value Share Analysis, by End-user, 2016 and 2024
Figure 27: North America Immunohematology Market Value Share Analysis, by Country, 2016 and 2025
Figure 28: North America Immunohematology Market Attractiveness Analysis, by Product
Figure 29: North America Immunohematology Market Attractiveness Analysis, by Application
Figure 30: North America Immunohematology Market Attractiveness Analysis, by End-user
Figure 31: Europe Immunohematology Market Size (US$ Mn) Forecast, 2017–2025
Figure 32: Europe Immunohematology Market Attractiveness, by Country/Sub-region
Figure 33: Europe Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 34: Europe Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 35: Europe Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 36: Europe Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 37: Europe Immunohematology Market Attractiveness, by Product
Figure 38: Europe Immunohematology Market Attractiveness, by Application
Figure 39: Europe Immunohematology Market Attractiveness,  by End-user
Figure 40: Asia Pacific Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 41: Asia Pacific Immunohematology Market Attractiveness, by Country/Sub-region, 2017–2025
Figure 42: Asia Pacific Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 43: Asia Pacific Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 44: Asia Pacific Immunohematology Market Value Share, by End-user, 2016 and 2025
Figure 45: Asia Pacific Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 46: Asia Pacific Immunohematology Market Attractiveness, by Product
Figure 47: Asia Pacific Immunohematology Market Attractiveness, by Application
Figure 48: Asia Pacific Immunohematology Market Attractiveness, by End-user
Figure 49: Latin America Immunohematology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 50: Latin America Immunohematology Market Attractiveness Analysis, by Country/Sub-region, 2017-25
Figure 51: Latin America Immunohematology Market Value Share Analysis, by Product, 2016 and 2025
Figure 52: Latin America Immunohematology Market Value Share Analysis, by Application, 2016 and 2025
Figure 53: Latin America Immunohematology Market Value Share Analysis by End-user, 2016 and 2024
Figure 54: Latin America Immunohematology Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
Figure 55: Latin America Immunohematology Market Attractiveness Analysis, by Product
Figure 56: Latin America Immunohematology Market Attractiveness Analysis, by Application
Figure 57: Latin America Immunohematology Market Attractiveness Analysis, by End-user
Figure 58: Middle East & Africa Immunohematology Market Size (US$ Mn) Forecast, 2015–2025
Figure 59: Middle East & Africa Immunohematology Market Attractiveness, by Country/Sub-region
Figure 60: Middle East & Africa Immunohematology Market Value Share, by Product, 2016 and 2025
Figure 61: Middle East & Africa Immunohematology Market Value Share, by Application, 2016 and 2025
Figure 62: Middle East & Africa Immunohematology Market Value Share, by End-user, 2016 and 2024
Figure 63: Middle East & Africa Immunohematology Market Value Share, by Country/Sub-region, 2016 and 2025
Figure 64: Middle East & Africa Immunohematology Market Attractiveness, by Product
Figure 65: Middle East & Africa Immunohematology Market Attractiveness, by Application
Figure 66: Middle East & Africa Immunohematology Market Attractiveness, by End-user
Figure 67: Market Share of Prominent Key Players: Immunohematology Market, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Immunohematology Market